The novel early predictive marker presepsin for postoperative pancreatic fistula: A pilot study.
pancreatic fistula
pancreaticoduodenectomy
presepsin
sCD14-ST
soluble CD14 subtype
Journal
Experimental and therapeutic medicine
ISSN: 1792-0981
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
03
01
2020
accepted:
26
03
2020
entrez:
9
8
2020
pubmed:
9
8
2020
medline:
9
8
2020
Statut:
ppublish
Résumé
Postoperative pancreatic fistula (PF) is a major and serious complication that occurs after pancreaticoduodenectomy (PD). The aim of the current study was to evaluate the use of a novel biomarker, presepsin, for predicting clinically relevant postoperative pancreatic fistula (CR-POPF) after PD. A prospective pilot study was conducted using 30 consecutive patients who underwent PD. Risk factors and candidates for predictive biomarkers for CR-POPF were statistically analyzed. CR-POPF (grade B and C; determined according to the guidelines of the International Study Group of Pancreatic Fistula) occurred in 15 patients (50%). Univariate analysis revealed that certain underlying conditions, including non-pancreatic cancer, smaller pancreatic ducts and soft pancreas texture were significantly associated with CR-POPF (P=0.005, P=0.004 and P=0.014, respectively). Furthermore, on day 1 post surgery (POD1), white blood cell count (P=0.040), levels of serum amylase (P=0.002) and serum presepsin (P=0.012), and the concentration of presepsin in drainage fluid (P<0.001) were significantly increased in CR-POPF compared with non-CR-POPF cases. Receiver operating characteristic curve analyses revealed that, on POD1, serum amylase and the concentration of presepsin in drainage fluid had an area under the curve value exceeding 0.8. A multivariate logistic regression analysis revealed that a higher concentration of presepsin in the drainage fluid was an independent predictive marker for CR-POPF (odds ratio, 14.503; 95% confidence interval, 1.750-120.229; P=0.013). To the best of our knowledge, the present study demonstrated for the first time that presepsin concentration in drainage fluid is a useful marker of CR-POPF after PD.
Identifiants
pubmed: 32765708
doi: 10.3892/etm.2020.8919
pii: ETM-0-0-8919
pmc: PMC7401571
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2298-2304Informations de copyright
Copyright © 2020, Spandidos Publications.
Références
J Gastrointest Surg. 2009 Oct;13(10):1845-51
pubmed: 19639369
J Gastrointest Surg. 2014 Jun;18(6):1108-15
pubmed: 24733259
HPB (Oxford). 2013 Feb;15(2):142-8
pubmed: 23297725
Surgery. 2017 Mar;161(3):584-591
pubmed: 28040257
Ann Surg. 2010 May;251(5):932-6
pubmed: 20395858
J Hepatobiliary Pancreat Sci. 2015 Jun;22(6):454-62
pubmed: 25678202
Dig Dis Sci. 2007 Jan;52(1):1-17
pubmed: 17205399
HPB (Oxford). 2014 Jul;16(7):610-9
pubmed: 24246024
Int J Surg. 2015 Sep;21 Suppl 1:S50-4
pubmed: 26118616
J Infect Chemother. 2005 Oct;11(5):234-8
pubmed: 16258819
HPB (Oxford). 2017 Jul;19(7):580-586
pubmed: 28392159
World J Gastrointest Pathophysiol. 2013 May 15;4(2):37-42
pubmed: 23755369
Surgery. 2014 Sep;156(3):601-10
pubmed: 24998158
Br J Surg. 2012 Aug;99(8):1072-5
pubmed: 22539219
J Gastrointest Surg. 2014 Feb;18(2):348-53
pubmed: 23903930
Ann Surg. 2006 Jul;244(1):1-7
pubmed: 16794381
J Hepatobiliary Pancreat Sci. 2011 Jul;18(4):601-8
pubmed: 21491103
Science. 1990 Sep 21;249(4975):1431-3
pubmed: 1698311
Pancreas. 2013 May;42(4):701-6
pubmed: 23429497
Hepatogastroenterology. 2009 Mar-Apr;56(90):519-23
pubmed: 19579634
Clin Chim Acta. 2015 Oct 23;450:97-103
pubmed: 26164388